Abstract
With the cancellation of the policy of “approval of third-party drug logistics business”, a large number of powerful enterprises that meet the conditions of modern pharmaceutical logistics have entered the pharmaceutical logistics. In this context, the introduction of third-party logistics service providers into the pharmaceutical supply chain system makes the problem study more practical. A three-level pharmaceutical supply chain operation mode was constructed, which was composed of pharmaceutical manufacturers, pharmaceutical distributors, third-party logistics service providers and retail pharmacies/ hospitals. By using game model, the relevant indicators under independent decision-making and cooperative decision-making can be compared and analyzed. The results show that in a certain range of cooperative cost, the performance index of pharmaceutical supply chain cooperative decision is significantly higher than that of independent decision. On this basis, considering two conditions that every supply chain member can obtain more benefits than that of independent decisions and the relative leadership of supply chain members, the cooperation benefits of pharmaceutical supply chain are reasonably distributed by three-distribution method based on profit distribution factors. Combined with the results, the elements affecting the profit distribution factor are explored, and the value range of the profit distribution factor is continuously reduced until the final result is determined and applied in practice, so as to ensure the stable cooperative operation of the pharmaceutical supply chain system.
Highlights
With the in-depth promotion of national medical reform, two-invoice system, pharmaceutical e-commerce and other related policies, the pharmaceutical logistics market will continue to grow at a rate of no less than 10% in the few years (Deng & Wen, 2019)
This paper studies the cooperative benefit distribution mechanism of pharmaceutical three-level supply chain with the participation of third-party logistics service providers
Without considering the cooperation cost, it is evident to see that the sales quantity and profit of pharmaceutical supply chain under cooperative decision-making are much higher than those under independent decision-making
Summary
With the in-depth promotion of national medical reform, two-invoice system, pharmaceutical e-commerce and other related policies, the pharmaceutical logistics market will continue to grow at a rate of no less than 10% in the few years (Deng & Wen, 2019). The research object of this paper is “pharmaceutical supply chain with the participation of thirdparty logistics”, taking the third-party logistics service provider as one of the stakeholders of pharmaceutical supply chain, studying various performance indicators under independent decision-making and cooperative decision-making of pharmaceutical supply chain members, and studying the reasonable value range of cooperation cost under cooperative decision-making On this basis, in view of the unreasonable distribution of benefits is often one of the reasons for the failure of cooperation, so, in order to ensure the stable cooperative operation of pharmaceutical supply chain, this paper further studies the mechanism of cooperative benefit distribution among supply chain members, so as to have a certain guiding role in practice
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
